BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhao YH, Leng SS, Wang Y, Kui FZ, Gan W. Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2025; 17(11): 110080 [PMID: 41368115 DOI: 10.4254/wjh.v17.i11.110080]
URL: https://www.wjgnet.com/1948-5182/full/v17/i11/110080.htm
Number Citing Articles
1
Monica Potra, Simona Popescu, Bogdan Timar, Sandra Lazar, Laura Gaita, Adina Braha, Teodora Sorescu, Laura Diaconu, Liana Iordan, Andreea Papoi, Adriana Ivanescu, Romulus Timar. Determinants of Metabolic Dysfunction-Associated Steatotic Liver Diseases in Patients with Type 2 Diabetes MellitusJournal of Clinical Medicine 2026; 15(16) doi: 10.3390/jcm15166421
2
Damian Świerczek, Maja Dreger, Jakub Jatkowski, Jakub Kancerek, Bogna Drozdzowska, Romuald Wojnicz. From Molecular Mechanisms to Clinical Strategies: A Comprehensive Overview of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)International Journal of Molecular Sciences 2026; 27(17) doi: 10.3390/ijms27177825